Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Quality of Life × Capecitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 13 Colorectal Neoplasms 6 Stomach Neoplasms 5 Neoplasm Metastasis 4 Biliary Tract Neoplasms 4 Pancreatic Neoplasms 3 Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Hepatocellular 3 Rectal Neoplasms 2 Colonic Neoplasms 2 Adenocarcinoma Of Esophagus 2 Resected Liver Metastases From Colorectal Cancer 1 Recurrence 1 Quality of Life 1 Oesophagogastric Cancer 1 Inflammatory Breast Neoplasms 1 HER2-positive Gastric Cancer 1 HER2-positive Breast Cancer 1 Gastroesophageal Junction Adenocarcinoma 1 Gallbladder Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Cholangiocarcinoma 1 Breast Diseases 1 Bile Duct Neoplasms 1 Anus Neoplasms 1 Adenocarcinoma 1

Interventions

endostar protein 1 Oxaliplatin 1 Chemoradiotherapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03577392 2019-04-04

EXECC

Sichuan Provincial People's Hospital

Phase 2/3 Unknown

Quality of Life

Data powered by HemOnc (CC BY 4.0) Colophon ⚡